Cohort of patients with acute hidrosadenitis in the Great West
Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
This study follows people with acute hidrosadenitis to see how the condition shows up in different ways, which could help improve treatment options.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 465 (estimated) |
| Sex | All |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 13 sites (Angers and 12 other locations) |
| Trial ID | NCT04352036 on ClinicalTrials.gov |
What this trial studies
This observational cohort aims to define the various phenotypes of acute hidrosadenitis to better understand the condition and tailor therapeutic approaches. By following patients diagnosed with this condition, the study seeks to gather data that will help characterize the different manifestations of acute hidrosadenitis. The insights gained could lead to improved management and treatment strategies for affected individuals.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with acute hidrosadenitis by a dermatologist who are willing to participate in the study.
Not a fit: Patients without social security affiliation or those under guardianship may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and effective treatment options for patients with acute hidrosadenitis.
How similar studies have performed: While this approach is observational and focuses on phenotype characterization, similar studies in other conditions have shown that understanding different disease manifestations can lead to significant advancements in treatment.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient diagnosed with acute hidrosadenitis by a dermatologist * Patient agreeing to be part of the study Exclusion Criteria: * Major under guardianship * Protected persons
Where this trial is running
Angers and 12 other locations
- CHU Angers — Angers, France (Recruiting)
- Chru Brest — Brest, France (Recruiting)
- CHD Vendée — La Roche-sur-Yon, France (Recruiting)
- CH La Rochelle — La Rochelle, France (Recruiting)
- Ch — Le Mans, France (Recruiting)
- CH bretagne sud — Lorient, France (Recruiting)
- CHU de Nantes - Dermatologie — Nantes, France (Recruiting)
- Chr D'Orléans — Orléans, France (Recruiting)
- CHU Milétrie — Poitiers, France (Recruiting)
- Ch de Cornouaille — Quimper, France (Recruiting)
- CHU Pontchaillou — Rennes, France (Recruiting)
- Ch Saint-Brieuc — Saint-Brieuc, France (Recruiting)
- CHRU Tours — Tours, France (Recruiting)
Study contacts
- Study coordinator: Brigitte Dreno, PU-PH
- Email: brigitte.dreno@wanadoo.fr
- Phone: 0240083118
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.